细胞癌-话题@MedSci

#细胞癌#

1086篇内容 | 2750人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1979282, encodeId=ef7719e928220, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JGH: 慢性丙型肝炎患者接受直接抗病毒药物治愈后肝细胞癌复发的危险因素分析, objectType=article, longId=294744, objectId=14cd294e44ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14cd294e44ed, replyNumber=0, likeNumber=67, createdTime=2022-08-10, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14cd294e44ed, moduleTitle=JGH: 慢性丙型肝炎患者接受直接抗病毒药物治愈后肝细胞癌复发的危险因素分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14cd294e44ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979313, encodeId=2c2a19e93137d, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=BMC Cancer：比较宫颈鳞状细胞癌（SCC）和腺癌/腺鳞癌（AC/ASC)）患者根治性放化疗后的生存结果, objectType=article, longId=302023, objectId=f6e5302023a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6e5302023a2, replyNumber=0, likeNumber=88, createdTime=2023-01-03, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6e5302023a2, moduleTitle=BMC Cancer：比较宫颈鳞状细胞癌（SCC）和腺癌/腺鳞癌（AC/ASC)）患者根治性放化疗后的生存结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6e5302023a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979267, encodeId=710f19e9267a2, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：Merkel细胞癌（MCC）的临床病理特点、治疗策略及影响预后的因素, objectType=article, longId=292943, objectId=93c2292943e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93c2292943e7, replyNumber=0, likeNumber=82, createdTime=2022-10-13, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93c2292943e7, moduleTitle=Front Oncol：Merkel细胞癌（MCC）的临床病理特点、治疗策略及影响预后的因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93c2292943e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979349, encodeId=aba919e9349be, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JGGD:头颈部基底细胞癌的皮镜手术对缩小切缘的研究, objectType=article, longId=730108, objectId=e6dee3010842, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6dee3010842, replyNumber=0, likeNumber=164, createdTime=2023-01-08, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6dee3010842, moduleTitle=JGGD:头颈部基底细胞癌的皮镜手术对缩小切缘的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e6dee3010842)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979363, encodeId=ab3919e9363e8, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=European Radiology：消融和腹腔镜肾部分切除术在治疗T1肾细胞癌方面的远期疗效, objectType=article, longId=736017, objectId=0692e3601796, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0692e3601796, replyNumber=0, likeNumber=88, createdTime=2022-08-18, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0692e3601796, moduleTitle=European Radiology：消融和腹腔镜肾部分切除术在治疗T1肾细胞癌方面的远期疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0692e3601796)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979226, encodeId=dd4519e922695, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：每周PCC方案（紫杉醇+卡铂+西妥昔单抗）可用于不适合EXTREME方案治疗复发和/或转移性头颈部鳞状细胞癌（R/M-HNSCC）患者, objectType=article, longId=219629, objectId=09d321962921, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=09d321962921, replyNumber=0, likeNumber=79, createdTime=2022-04-01, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=09d321962921, moduleTitle=Front Oncol：每周PCC方案（紫杉醇+卡铂+西妥昔单抗）可用于不适合EXTREME方案治疗复发和/或转移性头颈部鳞状细胞癌（R/M-HNSCC）患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=09d321962921)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979339, encodeId=fa2019e9339b1, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=JAMA子刊：转移性透明细胞肾细胞癌患者行细胞减灭性肾切除术后的生存结局如何？, objectType=article, longId=728115, objectId=21f4e28115d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=21f4e28115d1, replyNumber=0, likeNumber=66, createdTime=2022-11-10, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=21f4e28115d1, moduleTitle=JAMA子刊：转移性透明细胞肾细胞癌患者行细胞减灭性肾切除术后的生存结局如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=21f4e28115d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979337, encodeId=4e1d19e933776, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Dermatol Ther：一线治疗Hedgehog抑制剂停药后基底细胞癌患者的治疗模式和预后, objectType=article, longId=727196, objectId=5f66e27196e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f66e27196e1, replyNumber=0, likeNumber=74, createdTime=2023-01-08, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f66e27196e1, moduleTitle=Dermatol Ther：一线治疗Hedgehog抑制剂停药后基底细胞癌患者的治疗模式和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f66e27196e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979231, encodeId=951719e923106, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clinical Infectious Disease: 纤维化4指数的变化可以作为丙型肝炎病毒根除后发生肝细胞癌高风险的预测指标, objectType=article, longId=219950, objectId=a6522199507a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a6522199507a, replyNumber=0, likeNumber=90, createdTime=2022-04-30, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a6522199507a, moduleTitle=Clinical Infectious Disease: 纤维化4指数的变化可以作为丙型肝炎病毒根除后发生肝细胞癌高风险的预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6522199507a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979200, encodeId=9c0119e92007e, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=CSCO 2021：秦叔逵教授报告阿可拉定一线治疗基线较重预后较差晚期肝细胞癌结果, objectType=article, longId=217674, objectId=aa6321e674ae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa6321e674ae, replyNumber=0, likeNumber=73, createdTime=2022-05-16, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa6321e674ae, moduleTitle=CSCO 2021：秦叔逵教授报告阿可拉定一线治疗基线较重预后较差晚期肝细胞癌结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa6321e674ae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979327, encodeId=e25119e932762, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=European Radiology：热消融在肝细胞癌治疗中的价值, objectType=article, longId=725952, objectId=a675e25952f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a675e25952f0, replyNumber=0, likeNumber=71, createdTime=2022-05-10, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a675e25952f0, moduleTitle=European Radiology：热消融在肝细胞癌治疗中的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a675e25952f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979197, encodeId=5aca19e91978f, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=肌肉减少症会增加非小细胞癌患者术后复发风险, objectType=article, longId=217591, objectId=2b9b21e591d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2b9b21e591d7, replyNumber=0, likeNumber=57, createdTime=2022-02-17, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2b9b21e591d7, moduleTitle=肌肉减少症会增加非小细胞癌患者术后复发风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2b9b21e591d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979277, encodeId=c7fe19e9277a4, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：Lenvatinib（仑伐替尼）在肝细胞癌中的真实世界疗效:一项回顾性多中心研究(ELEVATOR), objectType=article, longId=294116, objectId=bee2294116f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bee2294116f4, replyNumber=0, likeNumber=81, createdTime=2022-08-03, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bee2294116f4, moduleTitle=Liver Cancer：Lenvatinib（仑伐替尼）在肝细胞癌中的真实世界疗效:一项回顾性多中心研究(ELEVATOR), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bee2294116f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979344, encodeId=dfab19e9344ac, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Lancet Oncol：纳武单抗联合卡博替尼治疗晚期肾细胞癌的长期预后, objectType=article, longId=729046, objectId=d601e290462b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d601e290462b, replyNumber=0, likeNumber=66, createdTime=2022-10-07, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d601e290462b, moduleTitle=Lancet Oncol：纳武单抗联合卡博替尼治疗晚期肾细胞癌的长期预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d601e290462b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979222, encodeId=2d7519e922240, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响, objectType=article, longId=219336, objectId=97b7219336b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97b7219336b4, replyNumber=0, likeNumber=60, createdTime=2022-08-28, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97b7219336b4, moduleTitle=Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97b7219336b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979189, encodeId=d4f819e91891c, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Clin Cancer Res：HDAC抑制剂Remetinostat凝胶用于基底细胞癌的治疗活性, objectType=article, longId=216890, objectId=3239216890aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3239216890aa, replyNumber=0, likeNumber=60, createdTime=2022-01-03, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3239216890aa, moduleTitle=Clin Cancer Res：HDAC抑制剂Remetinostat凝胶用于基底细胞癌的治疗活性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3239216890aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979358, encodeId=b6fa19e9358eb, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Eur J Clin Pharmacol：氢氯噻嗪的长期使用与皮肤和嘴唇鳞状细胞癌的发生有关, objectType=article, longId=733987, objectId=d48de339877b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d48de339877b, replyNumber=0, likeNumber=100, createdTime=2023-05-31, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d48de339877b, moduleTitle=Eur J Clin Pharmacol：氢氯噻嗪的长期使用与皮肤和嘴唇鳞状细胞癌的发生有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d48de339877b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979257, encodeId=b32f19e9257a8, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Liver Cancer：影像学应答是伴有肉眼血管侵犯(MVI)的晚期肝细胞癌患者应用TACE+RT治疗时的显著预后指标, objectType=article, longId=221712, objectId=37eb221e1225, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37eb221e1225, replyNumber=0, likeNumber=81, createdTime=2022-10-29, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37eb221e1225, moduleTitle=Liver Cancer：影像学应答是伴有肉眼血管侵犯(MVI)的晚期肝细胞癌患者应用TACE+RT治疗时的显著预后指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37eb221e1225)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979221, encodeId=3c4e19e9221a7, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=Front Oncol：仑伐替尼（lenvatinib）对比索拉非尼（Sorafenib）治疗晚期肝细胞癌的疗效：倾向评分匹配（PSM）分析, objectType=article, longId=219316, objectId=14432193166f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=14432193166f, replyNumber=0, likeNumber=70, createdTime=2021-12-01, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14432193166f, moduleTitle=Front Oncol：仑伐替尼（lenvatinib）对比索拉非尼（Sorafenib）治疗晚期肝细胞癌的疗效：倾向评分匹配（PSM）分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=14432193166f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1979359, encodeId=e76219e935957, content=<a href='/topic/show?id=3b90e79787f' target=_blank style='color:#2F92EE;'>#细胞癌#</a>, objectTitle=HAEMOPHILIA：直接抗病毒药物时代血友病患者肝细胞癌的患病率和危险因素：一项全国住院患者样本研究, objectType=article, longId=734060, objectId=6f1fe3406031, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f1fe3406031, replyNumber=0, likeNumber=97, createdTime=2023-03-12, rootId=0, userName=qingting, userId=e457184, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f1fe3406031, moduleTitle=HAEMOPHILIA：直接抗病毒药物时代血友病患者肝细胞癌的患病率和危险因素：一项全国住院患者样本研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f1fe3406031)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

细胞癌

2020-05-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JGH: 慢性丙型肝炎患者接受直接抗病毒药物治愈后肝细胞癌复发的危险因素分析

2022-08-10

qingting (审核中...)

前往app查看评论内容

#细胞癌#

BMC Cancer：比较宫颈鳞状细胞癌（SCC）和腺癌/腺鳞癌（AC/ASC)）患者根治性放化疗后的生存结果

2023-01-03

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：Merkel细胞癌（MCC）的临床病理特点、治疗策略及影响预后的因素

2022-10-13

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JGGD:头颈部基底细胞癌的皮镜手术对缩小切缘的研究

2023-01-08

qingting (审核中...)

前往app查看评论内容

#细胞癌#

European Radiology：消融和腹腔镜肾部分切除术在治疗T1肾细胞癌方面的远期疗效

2022-08-18

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：每周PCC方案（紫杉醇+卡铂+西妥昔单抗）可用于不适合EXTREME方案治疗复发和/或转移性头颈部鳞状细胞癌（R/M-HNSCC）患者

2022-04-01

qingting (审核中...)

前往app查看评论内容

#细胞癌#

JAMA子刊：转移性透明细胞肾细胞癌患者行细胞减灭性肾切除术后的生存结局如何？

2022-11-10

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Dermatol Ther：一线治疗Hedgehog抑制剂停药后基底细胞癌患者的治疗模式和预后

2023-01-08

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clinical Infectious Disease: 纤维化4指数的变化可以作为丙型肝炎病毒根除后发生肝细胞癌高风险的预测指标

2022-04-30

qingting (审核中...)

前往app查看评论内容

#细胞癌#

CSCO 2021：秦叔逵教授报告阿可拉定一线治疗基线较重预后较差晚期肝细胞癌结果

2022-05-16

qingting (审核中...)

前往app查看评论内容

#细胞癌#

European Radiology：热消融在肝细胞癌治疗中的价值

2022-05-10

qingting (审核中...)

前往app查看评论内容

#细胞癌#

肌肉减少症会增加非小细胞癌患者术后复发风险

2022-02-17

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：Lenvatinib（仑伐替尼）在肝细胞癌中的真实世界疗效:一项回顾性多中心研究(ELEVATOR)

2022-08-03

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Lancet Oncol：纳武单抗联合卡博替尼治疗晚期肾细胞癌的长期预后

2022-10-07

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：免疫相关不良事件(irAEs)对晚期肝细胞癌患者使用免疫检查点抑制剂(ICIs)疗效的影响

2022-08-28

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Clin Cancer Res：HDAC抑制剂Remetinostat凝胶用于基底细胞癌的治疗活性

2022-01-03

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Eur J Clin Pharmacol：氢氯噻嗪的长期使用与皮肤和嘴唇鳞状细胞癌的发生有关

2023-05-31

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Liver Cancer：影像学应答是伴有肉眼血管侵犯(MVI)的晚期肝细胞癌患者应用TACE+RT治疗时的显著预后指标

2022-10-29

qingting (审核中...)

前往app查看评论内容

#细胞癌#

Front Oncol：仑伐替尼（lenvatinib）对比索拉非尼（Sorafenib）治疗晚期肝细胞癌的疗效：倾向评分匹配（PSM）分析

2021-12-01

qingting (审核中...)

前往app查看评论内容

#细胞癌#

HAEMOPHILIA：直接抗病毒药物时代血友病患者肝细胞癌的患病率和危险因素：一项全国住院患者样本研究

2023-03-12

科室
- - 订阅+
  - 更多科室
工具
服务